IRADIMED CORP — Director's Dealing 2023

Dec 5, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IRADIMED CORP (IRMD)
CIK: 0001325618
Period of Report: 2023-12-01

Reporting Person: HAWKINS JAMES B (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-12-01	Common Stock	A	5259	$7.10	Acquired	41821	Direct
2023-12-01	Common Stock	S	5259	$43.2769	Disposed	36562	Direct
2023-12-04	Common Stock	A	4273	$7.10	Acquired	40835	Direct
2023-12-04	Common Stock	S	4273	$42.7041	Disposed	36562	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-12-01	Stock Options (Right to Buy)	$7.10	M	5259	Disposed	2024-09-29	Common Stock (5259)	Direct
2023-12-04	Stock Options (Right to Buy)	$7.10	M	4273	Disposed	2024-09-29	Common Stock (4273)	Direct

Footnotes

F1: This option, representing a right to purchase a total of 10,000 shares, was granted on 9-29-2014 and vested over 4 years in equal annual installments commencing on the first anniversary of the grant date.

F2: This transaction was executed in multiple trades at prices ranging from $42.70 to $43.72. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F3: This transaction was executed in multiple trades at prices ranging from $42.70 to $42.78. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.